A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LA / lupus anticoagulant

[Related PubMed/MEDLINE]
Total Number of Papers: 965
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LA  (>> Co-occurring Abbreviation)
Long Form:   lupus anticoagulant
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Altered platelet proteome in lupus anticoagulant (LA)-positive patients-protein disulfide isomerase and NETosis as new players in LA-related thrombosis. APS, NET, TE
2020 Coagulation mixing studies: Utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests. NRR/NRI
2020 Magnesium-dependent activated partial thromboplastin time assay-Simple method for lupus anticoagulant detection. aPL, APS, APTT
2020 Prevalence of antiphospholipid antibodies in Behcet's disease: A systematic review and meta-analysis. aCL, aPLs, BD, beta2GPI, CIs, NOS, ORs
2019 A diagnostic solution for haemostasis laboratories for patients taking direct oral anticoagulants using DOAC-Remove. APTT, DOAC, dRVVT, dTT
2019 Acute myocardial infarction and transient elevated anticardiolipin antibody in a young adult with possible familial hypercholesterolemia: a case report : Anticardiolipin antibody and myocardial infarction. CAG, ECG, FH, MI
2019 Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements. aCL, aPL, APS, SN-APS
2019 An invitro model to mimic the thrombotic occlusion of small vessels in catastrophic antiphospholipid syndrome (CAPS). abeta2GPI, aCL, ADP, APS, CAPS, CAPS, PFA
2019 Anti-domain 1 of beta2-glycoprotein I aids risk stratification in lupus anticoagulant-positive patients. aCL, anti-beta2GPI, anti-D1, APOs, CI, OR, TE
10  2019 Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study. aPL, LR, SLE
11  2019 Antiphospholipid antibodies are associated with positive screening for common mental disorders in women with previous pregnancy loss. The NOHA-PSY observational study. aPL Abs, APS, RR
12  2019 Antiphospholipid syndrome's genetic and epigenetic aspects. aCL
13  2019 Assessment of Normative Range and Deriving Cut-Off Values for Lupus Anticoagulant Testing: An Experience from a Tertiary Care Center in Southern India. dRVVT, LA-aPTT
14  2019 Clinical and laboratory practice for lupus anticoagulant testing: An International Society of Thrombosis and Haemostasis Scientific and Standardization Committee survey. ---
15  2019 Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository. ---
16  2019 Consultative Interpretation for Lupus Anticoagulant by Expert Pathologist Reduces False-Positive Rates in the Era of Direct Oral Anticoagulants. aPL, DOAC, dRVVT, dRVVTs, PTT-LA
17  2019 Dilute Russell viper venom time interpretation and clinical correlation: A two-year retrospective institutional review. APS, dRVVT, ISTH
18  2019 Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation. abeta2-GPIs, aCLs, aPLs, APS
19  2019 High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant. CI, OR, WOG
20  2019 How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors. APTT, LMWH, UFH
21  2019 Impact of different preanalytical conditions on results of lupus anticoagulant tests. DRVVT, SCT
22  2019 Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives. DOACs, RVVT
23  2019 Low extracellular vesicle-associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosis. aCL, anti-beta2GPI, APLAs, aPTT-LA, EVs, IQR, TF
24  2019 Lupus anticoagulant assay cut-offs vary between reagents even when derived from a common set of normal donor plasmas. NSCR
25  2019 Lupus anticoagulant diagnosis in patients receiving direct oral FXa inhibitors at trough levels: A real-life study. APTT, dRVVT, SCT
26  2019 Lupus anticoagulant-hypoprothrombinemia syndrome and similar diseases: experiences at a single center in Japan. FII, LAHPS, LLS
27  2019 Managing antiphospholipid syndrome in pregnancy. aCL, aPL, APS, OAPS
28  2019 Mixing studies for lupus anticoagulant: mostly no, sometimes yes. NPP
29  2019 Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): A comparative study using DOAC Stop and andexanet alfa. RVVT
30  2019 New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches. aCL, aPL, APS, MHC
31  2019 Paired APTTs of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVT. APTT, dAPTT, dRVVT
32  2019 Performance evaluation of Revohem™ FVIII chromogenic and Revohem™ FIX chromogenic in the CS-5100 autoanalyser. CSA, HA, VWD
33  2019 Pregnancy Management in Women with Antiphospholidic Syndrome. aCL, aPL, FGR, PE
34  2019 Prevalence and associations of anti-phosphatidylserine/prothrombin antibodies with clinical phenotypes in patients with primary antiphospholipid syndrome: aPS/PT antibodies in primary antiphospholipid syndrome. aPL, APS
35  2019 Relevance of antiphospholipid antibody profile in the clinical outcome of ITP: a single-centre study. APA, beta2GPI, ITP
36  2019 Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study. aPL, APS, VKA
37  2019 Resolving DOAC interference on aPTT, PT, and lupus anticoagulant testing by the use of activated carbon. AC, APTT, DOACs, PT
38  2019 Ruling out lupus anticoagulants with mixing test-specific cutoff assessment and the index of circulating anticoagulant. APTT, dAPTT, dRVVT, ICA, MTC
39  2019 The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants. APS, APTT, DOACs, dRVVT
40  2019 The Russell viper venom time (RVVT) test for investigation of lupus anticoagulant (LA). APS, LAs, RVVT
41  2019 Thrombotic Risk of Non-Criteria Anti-Phospholipid Antibodies Measured by Line Immunoassay: Superiority of Anti-Phosphatidylserine and Anti-Phosphatidic Acid Antibodies. aPLs, CL, GPI, LIA, OR
42  2019 Treatment of the antiphospholipid syndrome with direct oral anticoagulantsPosition statement of German societies. ACA, APS, beta2GPI-Ab, TE
43  2019 Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjogren's syndrome differ in molecular signatures and treatment perspectives. IgG, ITGB1, ROC, SLE
44  2019 Validity of Coagulation Activation Markers in Antiphospholipid Syndrome: A Systematic Review and Meta-analysis with a Short Data Report. aCL, aPL, APS, aPT, ES, PAPS, SLE, TAT
45  2019 [Adrenal hemorrhage in a patient with systemic lupus erythematosus]. aCL, ANA, BP, CRP, CT, ESR, HCQ, Hgb, SLE
46  2019 [Identification of compound heterozygous mutations of F11 gene in a pedigree affected with heriditary coagulation factor XI deficiency]. APTT, ELISA, F.IXC, FIB, FVIIIC, FXI, FXIAg, FXIC, FXIIC, PT
47  2019 [The clinical characteristics of antiphospholipid syndrome associated with chronic thromboembolic pulmonary hypertension]. aCL, APS, CTEPH, CTPA, PTE, WHO
48  2018 An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform. APTT
49  2018 Anaphylaxis Following Human Prothrombin Complex Concentrate in a Child with Lupus Anticoagulant Hypoprothrombinemia Syndrome: A Cautionary Tale. APTT, LAHS, PT
50  2018 Anti-annexin A5 antibodies and 25-hydroxy-cholecalciferol in female patients with primary antiphospholipid syndrome. aanxA5, abeta2gpI, aCL, VAPS
51  2018 Antiphospholipid antibodies in women with severe preeclampsia and placental insufficiency: a case-control study. abeta2GPI, aCL, AORs, aPL, APS, BMI, IgG, IgM, PREPI
52  2018 Antiphospholipid syndrome - an update. aPL, APS, b2-GPI, CAPS
53  2018 Clinical feature and anti-phospholipid antibody profiles of pregnancy failure in young women with antiphospholipid antibody syndrome treated with conventional therapy. aPL, APS, CL, PS/PT
54  2018 Distinguishing lupus anticoagulants from factor VIII inhibitors in haemophilic and non-haemophilic patients. CBA, FLI, FVIII, HA, Ig, NBA
55  2018 Does rotational thromboelastometry accurately predict coagulation status in patients with lupus anticoagulant? APTT, CT, DRVVT, PL, PT, ROTEM
56  2018 Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays. APTT, PT
57  2018 Further Investigations of the Effects of Anti-beta2GP1 Antibodies on Collagen-Induced Platelet Aggregation. anti-beta2GP1
58  2018 Identifying Additional Risk Factors for Thrombosis and Pregnancy Morbidities Among Antiphospholipid Antibodies Carriers. aPL, APS, CI, OR
59  2018 Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual. aCL, anti-beta2 GPI, aPL, APS, CI, Ig, OR, SLE
60  2018 Influence of autoimmunity and inflammation on endothelial function and thrombosis in systemic lupus erythematosus patients. vWF
61  2018 Interference of DOACs in different DRVVT assays for diagnosis of lupus anticoagulants. APS, DOACs
62  2018 Left ventricular diastolic abnormalities other than valvular heart disease in antiphospholipid syndrome: An echocardiographic study. aGAPSS, APS, BMI, CAD, LV, VHD
63  2018 Lupus anticoagulant hypoprothrombinemia syndrome associated with systemic lupus erythematosus in children: report of two cases and systematic review of the literature. ANA, APTT, dsDNA, LAHPS, PT, SLE
64  2018 Lupus anticoagulant mixing tests for multiple reagents are more sensitive if interpreted with a mixing test-specific cut-off than index of circulating anticoagulant. APTT, dAPTT, ICA, MTC
65  2018 Lupus anticoagulant testing using two parallel methods detects additional cases and predicts persistent positivity. aB2GPI, aCL, aPL
66  2018 Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity. dRVVT, HBM, LD, NAPs, TSVT/ET
67  2018 Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis. aCL, anti-beta2GPI, aPL, SSc, VT
68  2018 Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria. APS, CAPS, DOACs, PS/PT, SN-APS
69  2018 Prevalence of Antiphospholipid Antibody Positivity and Association of Pretransplant Lupus Anticoagulant Positivity With Early Allograft Dysfunction in Liver Transplantation. aCL, anti-beta2GPI, aPL, EAD, IPTW, LDLT
70  2018 Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome. aCL, aPL, APS, CR, eGFR, LN
71  2018 Rituximab use in pediatric lupus anticoagulant hypoprothrombinemia syndrome - report of three cases and review of the literature. FII, GCs, LA-HPS, PT, PTT, RTX, SLE
72  2018 Role of lupus anticoagulants in immediate acting inhibitor positivity in congenital haemophilia A patients. FVIII, IAIs, ITI, NBA
73  2018 The Clinical Relevance of Noncriteria Antiphospholipid Antibodies. aCL, anti-beta2GPI, aPL, APS
74  2018 The Lupus Anticoagulant Paradox. ---
75  2018 Thrombophilia Caused by Beta2-Glycoprotein I Deficiency: In Vitro Study of a Rare Mutation in APOH Gene. apo H, AT, beta2GPI, PC, PS, TM
76  2018 What should be the laboratory approach against isolated prolongation of a activated partial thromboplastin time? ---
77  2018 [Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome]. abeta2GPI, aCL, APS, APS-SH, CAPS, MHA, SLE
78  2018 [Systemic lupus erythematosus with acquired hemophilia A: a case report]. AHA, APTT, FVIII, SLE
79  2017 A combined approach using global coagulation assays quickly differentiates coagulation disorders with prolonged aPTT and low levels of FVIII activity. AHA, APC, CWA, TGT
80  2017 Antiphospholid antibodies and the risk of pregnancy complications. abeta2GP1, aCL, aPL Abs
81  2017 Antiphospholipid antibodies disappearance in primary antiphospholipid syndrome: Thrombosis recurrence. DVT
82  2017 Antiphospholipid syndrome and recurrent miscarriage: A systematic review and meta-analysis. abeta2GPI, aCL, aPLs, aPS, APS, RM
83  2017 Application of different lupus anticoagulant diagnostic algorithms to the same assay data leads to interpretive discrepancies in some samples. dAPTT, dRVVT
84  2017 Assessment of the underlying causes of the immune thrombocytopenia: Ten years experience. ANA, ITP
85  2017 Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant. aPTT-LA, LATS, SHR, TEs
86  2017 Clinical characteristics and laboratory findings of 252 Chinese patients with anti-phospholipid syndrome: comparison with Euro-Phospholipid cohort. aCL, APS, SAPS, SLE
87  2017 Clinical significance of anti-domain 1 beta2-glycoprotein I antibodies in antiphospholipid syndrome. aCL, anti-D1 beta2GPI, aPL, APS
88  2017 Clinical usefulness of the dilute Russell viper venom time test for patients taking warfarin. BCSH, CLSI, DRVVT, INR, ISTH, NPP
89  2017 Coagulation Testing in the Core Laboratory. APLS, APTT, DOACs, DTIs, TF
90  2017 Coexistence of anti-beta2-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies suggests strong thrombotic risk. anti-CL, aPLs, CI, OR
91  2017 Comorbid association of antiphospholipid antibodies and migraine: A systematic review and meta-analysis. aCL, aPLs, beta2GPI, CI, NOS, OR
92  2017 Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients. abeta2GPI, aCL, APS, ELISA
93  2017 Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting. API, DAB, RIV
94  2017 Incidence of Antiphospholipid Antibodies in Patients With Immune Thrombocytopenia and Correlation With Treatment With Steroids in North Indian Population. aCL, APLAs, beta2GP1, IgG, ITP
95  2017 Laboratory assessment of Activated Protein C Resistance/Factor V-Leiden and performance characteristics of a new quantitative assay. ---
96  2017 Lupus Anticoagulant Testing: Diluted Russell Viper Venom Time (dRVVT). dRVVT, NOACs, TT, VKAs
97  2017 Non-Criteria or Seronegative Obstetric Antiphospholipid Syndrome? abeta2GPI, Obs-APS, SLE
98  2017 Novel diagnostic and therapeutic frontiers in thrombotic anti-phospholipid syndrome. aCL, aPL, APS, beta2GPI, VKA
99  2017 Presence of Anticardiolipin Antibodies in Patients with Dementia: A Systematic Review and Meta-Analysis. aCL, anti-beta2GPI, CIs, ORs
100  2017 Prevalence of lupus anticoagulant in women with spontaneous abortion in Zaria. APTT, KCT, PT, SA